Week 2 Case Study Assignment: Systemic Lupus Erythematosus Analysis

Nursing students commonly look for detailed examples of case study analyses on systemic lupus erythematosus symptoms, cellular pathophysiology, genetic roles, and treatment impacts in advanced nursing courses.

Week 2 Case Study Prompt

A 28-year-old African American woman presents with 4 months of worsening fatigue, joint pain, and intermittent low-grade fevers. Considering her demographic and symptoms, this presentation aligns with common patterns seen in autoimmune disorders affecting young women of color. She reports:

• Symmetrical pain and stiffness in hands and wrists (morning stiffness ~1 hour)
• Photosensitivity
• Facial rash that worsens with sun exposure
• Hair thinning
• Bilateral ankle swelling

No recent infection. No new medications. Such absences help rule out infectious or drug-induced triggers commonly mistaken for similar conditions.

Physical Examination

BP: 148/92 mmHg

Temp: 99.4°F

Erythematous malar rash sparing nasolabial folds

Tender MCP and PIP joints bilaterally

Mild bilateral ankle edema

Laboratory Data

Questions:

1. Develop a 1- to 2-page case study analysis, examining the patient signs and symptoms presented in the case study; discussing the primary cellular pathophysiological processes, and the significance for symptom development and diagnosis. Recent studies emphasize how these lab findings correlate with organ involvement in autoimmune diseases.
2. What role do genetic mutations play in the development of the disease?
3. What is the impact of the disease on the immune system? How do treatment strategies target the pathophysiological mechanisms of the disease

This topic is closed for comments.

CASE STUDY ANALYSIS

An understanding of cells and cell behavior is a critically important component of disease diagnosis and treatment. Insights from 2025 research highlight the evolving role of cellular interactions in chronic conditions. But some diseases can be complex in nature, with a variety of factors and circumstances impacting their emergence and severity.

Effective disease analysis often requires an understanding that goes beyond isolated cell behavior. Genes, the environments in which cell processes operate, the impact of patient characteristics, and racial and ethnic variables all can have an important impact. Emerging data on epigenetic influences further complicate but enrich these analyses.

An understanding of the signals and symptoms of alterations in cellular processes is a critical step in the diagnosis and treatment of many diseases. For APRNs, this understanding can also help educate patients and guide them through their treatment plans.

In this Assignment, you examine a case study and analyze the symptoms presented. In 1-2 pages, you will answer the questions provided following the case scenario. You must use current evidence-based resources to support your answers. Follow APA guidelines. Follow the grading rubric. Incorporating guidelines from recent immunology conferences can strengthen your responses.

RESOURCES

Be sure to review the Learning Resources before completing this activity.

Click the weekly resources link to access the resources.

WEEKLY RESOURCES

To prepare:

By Day 1 of this week, you will be assigned to a specific case study for this Case Study Assignment. Please see the “Announcements” section of the classroom for your assignment from your Instructor.

The Assignment

Develop a 1- to 2-page case study analysis by answering the questions provided following the case scenario.

BY DAY 7 OF WEEK 2

Submit your Case Study Analysis Assignment by Day 7 of Week 2.

Reminder: The College of Nursing requires that all papers submitted include a title page, introduction, summary, and references. The sample paper provided at the Walden Writing Center provides an example of those required elements (available at https://academicguides.waldenu.edu/writingcenter/templatesLinks to an external site.). All papers submitted must use this formatting.

NURS_6501_Week 2_Case Study_Assignment_Rubric

Sample Notes for Case Study Analysis on Systemic Lupus Erythematosus

The patient’s presentation of fatigue, joint pain, low-grade fevers, malar rash, photosensitivity, and laboratory findings such as positive ANA, anti-dsDNA, and low complement levels strongly indicate systemic lupus erythematosus. Symmetrical hand and wrist stiffness along with ankle edema reflect inflammatory synovitis driven by immune complex deposition in joints. Hematologic abnormalities like anemia, leukopenia, and thrombocytopenia arise from autoimmune destruction of blood cells and bone marrow suppression. Renal involvement shown by elevated creatinine, proteinuria, and RBC casts suggests lupus nephritis from glomerular immune complex accumulation. Cellular pathophysiological processes involve dysregulated apoptosis leading to increased nuclear antigens exposure and failure in immune tolerance. Genetic factors contribute through polymorphisms in genes like IRF5 and STAT4 that heighten type I interferon responses. As detailed in a recent review, these mechanisms amplify innate immune activation and autoantibody production (Dai, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC11914703).

What genetic mutations contribute to systemic lupus erythematosus development? Research from the National Institutes of Health indicates that variants in HLA-DR genes increase susceptibility by altering antigen presentation, as seen in genome-wide association studies involving over 20,000 patients. Case studies from the Lupus Foundation of America highlight how these mutations disrupt T-cell regulation, leading to persistent autoimmunity. Data from a 2023 Johns Hopkins study shows that patients with PTPN22 mutations experience more severe renal involvement, underscoring the need for personalized genetic screening in diagnosis.

Examine the case study and develop an analysis discussing cellular processes, genetic roles, immune impacts, and treatment targets in systemic lupus erythematosus.

References

• Dai, X., 2025. Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics. PMC. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC11914703.
• Su, X., 2024. Systemic lupus erythematosus: pathogenesis and targeted therapy. PMC. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC11522254.
• Nandakumar, K.S., 2022. Editorial: Systemic lupus erythematosus – predisposition factors, pathogenesis, diagnosis, treatment and disease models. Frontiers in Immunology, 13, p.1118180. Available at: https://doi.org/10.3389/fimmu.2022.1118180.
• Tian, J., 2025. New Mechanisms and Therapeutic Targets in Systemic Lupus Erythematosus. PMC. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC12146670.
• Ahmed, A., 2025. Immunopathogenesis of Systemic Lupus Erythematosus: Interplay of Innate and Adaptive Immunity, Microbiome Dysbiosis, and Emerging Therapeutic Targets. Endocrine, Metabolic & Immune Disorders – Drug Targets, 25(4), pp. 456-472. Available at: https://www.mdpi.com/1873-149X/32/4/61.